S2001: Randomized Phase II Clinical Trial of Olaparib + Pembrolizumab vs. Olaparib Alone as Maintenance Therapy in Metastatic Pancreatic Cancer Patients with Germline BRCA1 or BRCA2 Mutations (Location: Sioux Falls)

Objective

Clinical Trial Details >>

Principal Investigator(s)

Benjamin Solomon, MD

Clinical Trial Categories

• Pancreatic Cancer

Contact

Medical Oncology Research Coordinators at 605-322-3295
or medoncresearch@avera.org